By Kerry Noonan
Anthony Walker, Managing Partner, discusses CAR-T therapy in an article titled Safety concerns blight promising cancer therapy in Nature News.
For more information on how we can assist your biotech or pharmaceutical project, please reach out.
Contact us today to learn how our pharma & biotech consulting expertise can serve your project.
Contact us© 2009-24 Alacrita Holdings Limited | Pharma & Biotech Consulting
Alacrita Consulting
2 Royal College St
London, UK
NW1 0NH
Registered in England & Wales.
No. 10530608
One Broadway
Floor 14
Cambridge, MA 02142
Registered in Massachusetts.